EIF3J expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.545000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.747800E-01
Normal-vs-Stage2
8.115800E-01
Normal-vs-Stage3
6.194800E-01
Normal-vs-Stage4
3.820200E-01
Stage1-vs-Stage2
6.213000E-01
Stage1-vs-Stage3
2.662600E-01
Stage1-vs-Stage4
8.151800E-01
Stage2-vs-Stage3
3.345200E-01
Stage2-vs-Stage4
5.191000E-01
Stage3-vs-Stage4
1.936040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.303400E-01
Normal-vs-AfricanAmerican
5.298000E-01
Normal-vs-Asian
7.026800E-01
Caucasian-vs-AfricanAmerican
3.725600E-01
Caucasian-vs-Asian
2.174200E-01
AfricanAmerican-vs-Asian
1.980190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.778000E-01
Normal-vs-Female
8.027600E-01
Male-vs-Female
8.757200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.442200E-01
Normal-vs-Age(41-60Yrs)
5.463000E-01
Normal-vs-Age(61-80Yrs)
9.932000E-01
Normal-vs-Age(81-100Yrs)
9.322800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.869200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.247400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.591000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.162500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.245600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.635400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.637000E-01
Normal-vs-Daily Drinker
8.660400E-01
Normal-vs-Weekly Drinker
9.240000E-01
Normal-vs-Occasional Drinker
8.340600E-01
Normal-vs-Social Drinker
8.581600E-01
Non Drinker-vs-Daily Drinker
4.663200E-01
Non Drinker-vs-Weekly Drinker
6.177000E-01
Non Drinker-vs-Occasional Drinker
8.997600E-01
Non Drinker-vs-Social Drinker
5.071400E-01
Daily Drinker-vs-Weekly Drinker
8.915200E-01
Daily Drinker-vs-Occasional Drinker
4.853400E-01
Daily Drinker-vs-Social Drinker
9.206600E-01
Weekly Drinker-vs-Occasional Drinker
6.099400E-01
Weekly Drinker-vs-Social Drinker
9.557400E-01
Occasional Drinker-vs-Social Drinker
4.960200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.292600E-01
Normal-vs-Grade 2
5.674200E-01
Normal-vs-Grade 3
7.105900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.340640E-01
Grade 1-vs-Grade 3
1.162440E-01
Grade 1-vs-Grade 4
3.292600E-01
Grade 2-vs-Grade 3
6.726400E-01
Grade 2-vs-Grade 4
5.674200E-01
Grade 3-vs-Grade 4
7.105900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.082000E-01
Normal-vs-NonDiabetic
9.159600E-01
Diabetic-vs-NonDiabetic
4.877000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.630800E-01
Normal-vs-NoPancreatitis
9.130800E-01
Pancreatitis-vs-NoPancreatitis
7.813000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.444000E-01
Normal-vs-N1
7.589600E-01
N0-vs-N1
3.775000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.932000E-01
Normal-vs-TP53-NonMutant
9.837600E-01
TP53-Mutant-vs-TP53-NonMutant
1.909770E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
